UKRAINS'KYI VISNYK PSYKHONEVROLOHII

The Scientific and Practical Journal of Medicine
ISSN 2079-0325(p)
DOI 10.36927/2079-0325

Pervasive developmental disorders with a complex structure (epileptic seizures, catatonic, hallucinatory and manic symptoms, delirious episodes during life)

Type of Article

In the Section

Index UDK:

Abstract

Observation of two patients with Phelan-McDermid syndrome (22q13.3 microdeletions of the SHANK3 gene) within 10—12 years allowed us to describe the clinical pathomorphism of psychotic episodes with violation of consciousness and catatonic symptoms in adolescence with autism spectrum disorders (ASD). The described phenotypes were characterized by intellectual disability, general speech underdevelopment, muscle hypotonia and developmental dyspraxia. Their causal relationships with epileptic encephalopathy, schizophrenia, bipolar and hyperkinetic disorders have been analyzed.

The therapeutic efficacy of combination therapy with aripiprazole and benzodiazepines (clonazepam/diazepam) allowed qualifying psychotic episodes as pediatric delirium.

The significant clinical efficacy of lithium and lamotrigine in the described patients was consistent with the hypothesis that microdeletion of the SHANK3 gene may be associated with bipolar disorder. Treatment of acute psychotic disorders with lithium salt was effective in both patients but had limitations due to poor tolerance in the long-term use.

The combination of lithium and lamotrigine may be recommended for the treatment of polymorbid mental disorders in patients with SHANK3 encephalopathies. If lithium salts are poorly tolerated, a combination of lamotrigine and aripiprazole may be used.

Pages

References

  1. Degenhardt F. Copy number variants in psychiatric disorders: Chapter 28. In: Personalized Psychiatry. Academic Press, 2020. P.  357—362. DOI: https://doi.org/10.1016/B978-0-12-813176-3.00028-6.
  2. Verhoeven W. M. A., Egger  J.  I.  M., de  Leeuw  N. A  longitudinal perspective on  the pharmacotherapy of  24 adult patients with Phelan McDermid syndrome // European journal of medical genetics. 2020. Vol. 63, issue 3. P. 103751. DOI: https://doi.org/10.1016/j.ejmg.2019.103751.
  3. Lithium as a rescue therapy for regression and catatonia features in two SHANK3 patients with autism spectrum disorder / S. Serret, S. Thümmler, E. Dor [et al.] // BMC psychiatry. 2015. Vol. 15. Article number 107. DOI: https://doi.org/10.1186/s12888-015-0490-1.
  4. Phelan-McDermid syndrome due to SHANK3 mutation in an intellectually disabled adult male: successful treatment with lithium / J. Egger, W. Verhoeven, R. Groenendijk-Reijenga [et al.] // BMJ case reports. 2017. bcr2017220778. DOI: https://doi.org/10.1136/bcr-2017-220778.
  5. Neuropsychopathology in 7 Patients with the 22q13 Deletion Syndrome: Presence of Bipolar Disorder and Progressive Loss of Skills  / A.  Denayer, H. Van  Esch, T.  De  Ravel [et  al.]  // Molecular syndromology. 2012. Vol. 3, issue 1. P. 14—20. DOI: https://doi.org/10.1159/000339119.